Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16

1.

Distinctive Expression and Amplification of Genes at 11q13 in Relation to HPV Status with Impact on Survival in Head and Neck Cancer Patients.

Hermida-Prado F, Menéndez ST, Albornoz-Afanasiev P, Granda-Diaz R, Álvarez-Teijeiro S, Villaronga MÁ, Allonca E, Alonso-Durán L, León X, Alemany L, Mena M, Del-Rio-Ibisate N, Astudillo A, Rodríguez R, Rodrigo JP, García-Pedrero JM.

J Clin Med. 2018 Dec 1;7(12). pii: E501. doi: 10.3390/jcm7120501.

2.

Factors Secreted by Cancer-Associated Fibroblasts that Sustain Cancer Stem Properties in Head and Neck Squamous Carcinoma Cells as Potential Therapeutic Targets.

Álvarez-Teijeiro S, García-Inclán C, Villaronga MÁ, Casado P, Hermida-Prado F, Granda-Díaz R, Rodrigo JP, Calvo F, Del-Río-Ibisate N, Gandarillas A, Morís F, Hermsen M, Cutillas P, García-Pedrero JM.

Cancers (Basel). 2018 Sep 17;10(9). pii: E334. doi: 10.3390/cancers10090334.

3.

Immunohistochemical Expression of Cortactin and Focal Adhesion Kinase Predicts Recurrence Risk and Laryngeal Cancer Risk Beyond Histologic Grading.

Villaronga MÁ, Hermida-Prado F, Granda-Díaz R, Menéndez ST, Álvarez-Teijeiro S, Quer M, Vilaseca I, Allonca E, Garzón-Arango M, Sanz-Moreno V, Astudillo A, Rodrigo JP, García-Pedrero JM.

Cancer Epidemiol Biomarkers Prev. 2018 Jul;27(7):805-813. doi: 10.1158/1055-9965.EPI-17-1082. Epub 2018 Apr 13.

PMID:
29654156
4.

Dysregulation of Mir-196b in Head and Neck Cancers Leads to Pleiotropic Effects in the Tumor Cells and Surrounding Stromal Fibroblasts.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Rodrigo JP, Manterola L, de Villalaín L, de Vicente JC, Alonso-Durán L, Fernández MP, Lawrie CH, García-Pedrero JM.

Sci Rep. 2017 Dec 19;7(1):17785. doi: 10.1038/s41598-017-18138-8.

5.

A Novel Role For Nanog As An Early Cancer Risk Marker In Patients With Laryngeal Precancerous Lesions.

Rodrigo JP, Villaronga MÁ, Menéndez ST, Hermida-Prado F, Quer M, Vilaseca I, Allonca E, Pedregal Mallo D, Astudillo A, García-Pedrero JM.

Sci Rep. 2017 Sep 11;7(1):11110. doi: 10.1038/s41598-017-11709-9.

6.

Annexin A1 down-regulation in head and neck squamous cell carcinoma is mediated via transcriptional control with direct involvement of miR-196a/b.

Álvarez-Teijeiro S, Menéndez ST, Villaronga MÁ, Pena-Alonso E, Rodrigo JP, Morgan RO, Granda-Díaz R, Salom C, Fernandez MP, García-Pedrero JM.

Sci Rep. 2017 Jul 28;7(1):6790. doi: 10.1038/s41598-017-07169-w.

7.

Cleavage of Fibulin-2 by the aggrecanases ADAMTS-4 and ADAMTS-5 contributes to the tumorigenic potential of breast cancer cells.

Fontanil T, Álvarez-Teijeiro S, Villaronga MÁ, Mohamedi Y, Solares L, Moncada-Pazos A, Vega JA, García-Suárez O, Pérez-Basterrechea M, García-Pedrero JM, Obaya AJ, Cal S.

Oncotarget. 2017 Feb 21;8(8):13716-13729. doi: 10.18632/oncotarget.14627.

8.

HERG1 potassium channel expression in potentially malignant disorders of the oral mucosa and prognostic relevance in oral squamous cell carcinoma.

Fernández-Valle Á, Rodrigo JP, Rodríguez-Santamarta T, Villaronga MÁ, Álvarez-Teijeiro S, García-Pedrero JM, Suárez-Fernández L, Lequerica-Fernández P, de Vicente JC.

Head Neck. 2016 Nov;38(11):1672-1678. doi: 10.1002/hed.24493. Epub 2016 Apr 30.

PMID:
27131339
9.

HERG1A potassium channel is the predominant isoform in head and neck squamous cell carcinomas: evidence for regulation by epigenetic mechanisms.

Menéndez ST, Villaronga MÁ, Rodrigo JP, Álvarez-Teijeiro S, Urdinguio RG, Fraga MF, Suárez C, García-Pedrero JM.

Sci Rep. 2016 Jan 20;6:19666. doi: 10.1038/srep19666.

10.

Clinical significance of Anoctamin-1 gene at 11q13 in the development and progression of head and neck squamous cell carcinomas.

Rodrigo JP, Menéndez ST, Hermida-Prado F, Álvarez-Teijeiro S, Villaronga MÁ, Alonso-Durán L, Vallina A, Martínez-Camblor P, Astudillo A, Suárez C, María García-Pedrero J.

Sci Rep. 2015 Oct 26;5:15698. doi: 10.1038/srep15698.

11.

eIF2 kinases mediate β-lapachone toxicity in yeast and human cancer cells.

Menacho-Márquez M, Rodríguez-Hernández CJ, Villaronga MÁ, Pérez-Valle J, Gadea J, Belandia B, Murguía JR.

Cell Cycle. 2015;14(4):630-40. doi: 10.4161/15384101.2014.994904.

12.

The transcription factor CREBZF is a novel positive regulator of p53.

López-Mateo I, Villaronga MÁ, Llanos S, Belandia B.

Cell Cycle. 2012 Oct 15;11(20):3887-95. doi: 10.4161/cc.22133. Epub 2012 Sep 14.

13.

Role of HERG1 potassium channel in both malignant transformation and disease progression in head and neck carcinomas.

Menéndez ST, Rodrigo JP, Alvarez-Teijeiro S, Villaronga MÁ, Allonca E, Vallina A, Astudillo A, Barros F, Suárez C, García-Pedrero JM.

Mod Pathol. 2012 Aug;25(8):1069-78. doi: 10.1038/modpathol.2012.63. Epub 2012 Mar 30.

14.

Identification and characterization of novel potentially oncogenic mutations in the human BAF57 gene in a breast cancer patient.

Villaronga MA, López-Mateo I, Markert L, Espinosa E, Fresno Vara JA, Belandia B.

Breast Cancer Res Treat. 2011 Aug;128(3):891-8. doi: 10.1007/s10549-011-1492-4. Epub 2011 Apr 5.

PMID:
21465167
15.

Repression of androgen receptor activity by HEYL, a third member of the Hairy/Enhancer-of-split-related family of Notch effectors.

Lavery DN, Villaronga MA, Walker MM, Patel A, Belandia B, Bevan CL.

J Biol Chem. 2011 May 20;286(20):17796-808. doi: 10.1074/jbc.M110.198655. Epub 2011 Mar 17.

16.

Identification of BAF57 mutations in human breast cancer cell lines.

Kiskinis E, García-Pedrero JM, Villaronga MA, Parker MG, Belandia B.

Breast Cancer Res Treat. 2006 Jul;98(2):191-8. Epub 2006 Mar 15.

Supplemental Content

Loading ...
Support Center